Cargando…
Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients
BACKGROUND: Suppressor of tumorigenicity 2 (ST2) is a key biomarker in inflammation and cardiovascular diseases, but limited data is available on its role in allergic rhinitis (AR). OBJECTIVE: The aim of this study is to explore the role of serum soluble ST2 (sST2) in evaluating disease severity and...
Autores principales: | Zhu, Kang, Xia, Cui, Chen, Jingguo, Yu, Chao, Gao, Tianxi, Yan, Jing, Shao, Na, Zhu, Pin, Sun, Bin, Ren, Xiaoyong, Zhang, Yanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181096/ https://www.ncbi.nlm.nih.gov/pubmed/34194284 http://dx.doi.org/10.1155/2021/5576596 |
Ejemplares similares
-
Outcome of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitive to House Dust Mites
por: Kim, Seon-Tae
Publicado: (2015) -
Early Compliance and Efficacy of Sublingual Immunotherapy in Patients with Allergic Rhinitis for House Dust Mites
por: Chang, Hyun, et al.
Publicado: (2009) -
House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis
por: Okamoto, Y., et al.
Publicado: (2016) -
Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022) -
Satisfaction of allergic patients treated with house dust mite sublingual immunotherapy
por: Aarestrup, Matheus Fonseca, et al.
Publicado: (2021)